Healthcare / Medical Devices / Signal Release

Press Release

Pheonix Research Releases 2026–2033 Medical Nonwoven Forecast: USD 21.65 Billion at Exactly the 7.00 Per Cent of the Supplies Market It Feeds

· Healthcare

FOR IMMEDIATE RELEASE

18 November 2026 — Pheonix Research has published its 2026–2033 forecast for the global medical nonwoven market, modelling USD 12.60 billion in 2025 rising to USD 21.65 billion in 2033: a compound annual growth rate of 7.00 per cent and 1.72 times the base year.

What makes the number worth reporting is what it does not do. Pheonix models the global medical supplies market — the finished goods the nonwoven layer is consumed by — at USD 168.50 billion in 2025 rising to USD 289.70 billion in 2033, also at 7.00 per cent. The two series move at the same rate, so nonwoven’s share of the supplies market goes from 7.48 per cent to 7.47 per cent across the whole forecast: no mix shift at all.

“A raw-material layer growing at exactly the rate of the finished-goods layer tells you the industry is not changing how much fabric sits inside a surgical pack, a gown or a drape,” said Pheonix Research’s healthcare and medical devices research team. “That is a genuinely useful negative result. It means the growth in this market is volume following procedures, not a re-specification story, and it means a supplier has to win share from another supplier rather than ride a richer mix.”

Key findings

  • Medical nonwoven: USD 12.60 billion in 2025 to USD 21.65 billion in 2033 — 7.00 per cent CAGR, 1.72 times the base year.
  • Medical supplies, the market it feeds: USD 168.50 billion to USD 289.70 billion, at the same 7.00 per cent.
  • Share of the supplies market: 7.48 per cent to 7.47 per cent — a decline of 0.01 points over eight years.
  • Ten tier-one players are profiled, including Kimberly-Clark and Medline.
  • The demand drivers the report identifies are infection prevention, the volume of surgical procedures and single-use adoption; the pressure it identifies is the shift toward sustainable and biodegradable substrates.
  • This edition publishes no tonnage or square-metre series. It is a value model.

“The sustainability question is where this market could break its own flat ratio,” the team added. “If a substrate substitution lands at scale, the same procedure consumes a different material at a different price and the mix stops being neutral. Nothing in the current value series shows that happening inside this forecast window — which is the useful thing to know before you underwrite a conversion line against it.”

The assumption that carries the forecast

The two series are Pheonix value models on the same 2025 base and the same 2033 horizon. The finding is not that both rates are 7.00 per cent by construction; each was modelled separately and the ratio emerged at 7.48 against 7.47. If nonwoven compounded at 5.5 per cent instead of 7.00 per cent, 2033 would be USD 19.34 billion rather than USD 21.65 billion and its share of supplies would fall measurably instead of holding. The claim is about mix, not about the absolute size of either market.

Report details

  • Title: Global Medical Nonwoven Market Report, Size and Forecast 2026-2033
  • Base year: 2025  ·  Forecast horizon: to 2033
  • Coverage: global
  • Chapters: Table of Contents, Competitive Landscape, Value Chain, Investment Activity, Technology & Innovation, Market Risk, Regulatory Landscape
  • Availability: Global Medical Nonwoven Market Report 2026-2033

About Pheonix Research

Pheonix Research publishes market intelligence on a live graph of more than 500 market, segment, industry, company and press-release nodes, translating market signals into role-specific decisions for procurement, strategy and executive teams. Each market report is modelled on stated assumptions and publishes the assumption that carries its forecast.

Media contact

Media and research enquiries: [email protected]
Commercial and licensing: [email protected]

— Ends —